Previous Article | Next Article ![]()
Journal of Virology, July 2003, p. 7502-7509, Vol. 77, No. 13
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.13.7502-7509.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Istituto di Ricerche di Biologia Molecolare P. Angeletti, 00040 Pomezia, Rome, Italy
Received 26 December 2002/ Accepted 31 March 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
A subgenomic replicon of GB virus B (GBV-B) that replicates in cell lines selected from human hepatoma Huh7 cells was previously described (10). The main interest in developing cell-based systems for GBV-B lies in the possibility of using this virus as an indirect but valid alternative to using HCV in animal models (4). In fact, HCV infects only chimpanzees, considered the nearest relative to humans, a fact which sets obvious limitations on the development of in vivo studies. On the contrary, the similar flavivirus GBV-B infects small monkeys, such as tamarins (Saguinus spp.) (3, 9, 39) and owl monkeys (Aotus spp.) (8), which present several advantages for research over apes (4).
The construction of chimeric molecules in which part of the GBV-B genome is substituted by its HCV counterpart would be a valuable tool for studying HCV in nonhuman primates, taking advantage of the capability of GBV-B to replicate in these animals. It is conceivable, however, that these chimeric species would not replicate as efficiently as the wild-type virus, since the necessary interactions among viral genomes and virus and/or host factors would involve elements derived from different parental viruses. Preliminary cell-based experiments are thus required to optimize constructs used to challenge cells and, eventually, animals. From this viewpoint, even a moderate enhancement in the replication performance of a construct might be crucial to identifying permissive host cells and "lead constructs" amenable to amelioration.
The work presented here originates from an observation made during experimental work to develop the GBV-B replicon system (10), based on the selection of permissive clones that depend on neomycin phosphotransferase gene expression driven by the IRES located in the 5' untranslated region (5'-UTR) of the GBV-B genome. We noticed that the efficiency of selection of permissive clones was reproducibly enhanced by the inclusion of the first 21 nucleotides (nt) of the GBV-B capsid protein (core) coding sequence immediately downstream of the GBV-B 5'-UTR and in frame with the selector gene.
In this study, we analyzed the effects on the translation of protein products under GBV-B IRES-mediated control and on the replication of subgenomic RNA achieved by the addition of 5'-terminal core coding sequences of different lengths downstream of the GBV-B 5'-UTR.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmids. The construction of the neo-RepB and bla-RepB GBV-B replicons, containing the first 21 nt following the AUG start codon of the core coding region upstream of the neomycin phosphotransferase (neo) and ß-lactamase (bla) genes, respectively, was previously described (10). The neo-RepA, neo-RepC, and neo-RepD constructs were obtained by replacing the BamHI-AscI fragment of neo-RepB with the corresponding fragment including no core coding sequence (neo-RepA) or 39 nt (neo-RepC) or 63 nt (neo-RepD) of core coding sequence after the AUG start codon. The bla-RepA, bla-RepC, and bla-RepD constructs, including the ß-lactamase (bla) reporter gene downstream of the GBV-B 5'-UTR, were obtained by replacing the AscI-PmeI fragment carrying the neomycin phosphotransferase gene of the neo-Rep constructs with the AscI-PmeI fragment of bla-RepB carrying the ß-lactamase gene. Mutations in the polymerase active site (GDD motif to GAA) were constructed for all of the replicon constructs as described previously (10).
Sequence analysis. Sequencing was performed as described previously (10).
Transfection of GBV-B replicon RNA and monitoring of replication. Human hepatoma Huh7 and cB76.1/Huh7 cell lines were used to test the replication of GBV-B replicon constructs. Linearized plasmids carrying replicons were in vitro transcribed by T7 RNA polymerase as described previously (10). Confluent cells from 15-cm plates were split 1:2. Cells were recovered after 24 h in 5 ml of medium, washed twice with 40 ml of cold diethyl pyrocarbonate-treated phosphate-buffered saline, filtered with Cell Striner filters (Falcon), and diluted in cold diethyl pyrocarbonate-treated phosphate-buffered saline at a concentration of 107cells/ml. Aliquots of 2 x 106 cells were subjected to electroporation with 10 µg of in vitro-transcribed RNA by two pulses at 0.35 kV and 10 µF with a Bio-Rad Genepulser II. Immediately after the electric pulses, the cells were diluted in 8 ml of complete Dulbecco's modified Eagle medium and processed with different protocols depending on the selection or tracer used. For transformation with constructs bearing the neomycin phosphotransferase gene, cells were divided into three 15-cm plates; on the following day, the selecting antibiotic G418 (Sigma G-9516) was added at 0.250 mg/ml. In 2 weeks, G418-sensitive cells died, and at week 4, surviving cell clones could be picked and expanded by growth in individual plates. When the ß-lactamase reporter gene was used, 5 x 105 to 7 x 105 transfected cells were plated in each well of six-well plates (Falcon) to be stained after 4 h with the membrane-permeating substrate CCF2 (Aurora Biosciences Corporation) (30, 43), which can be hydrolyzed by the intracellular ß-lactamase, resulting in a fluorescence shift from green to blue. When quantitative PCR was used to measure transient replication after the transfection of either bla-Rep or neo-Rep RNA, 1 x 105 to 2 x 105 cells were plated in each well of six-well plates. After 3 days, total RNA was purified as described for the TRIzol protocol (Life Technologies), and 10 µl from the 100 µl of total RNA recovered was used in each TaqMan reaction. The electroporation efficiency was monitored by measuring intracellular specific RNA soon after electroporation by the TaqMan reaction.
TaqMan quantification of GBV-B RNA. GBV-B RNA was quantified by a real-time, 5' exonuclease PCR (TaqMan) assay with a primer-probe set that recognized a portion of the GBV-B 5'-UTR. The primers (GBV-B-F3, GTAGGCGGCGGGACTCAT; and GBV-B-R3, TCAGGGCCATCCAAGTCAA) and the probe (GBV-B-P3, 6-carboxyfluorescein-TCGCGTGATGACAAGCGCCAAG-N,N,N',N'-tetramethyl-6-carboxyrhodamine) were selected by using Primer Express software (PE Applied Biosystems). The primers were used at 10 pmol/50-µl reaction, and the probe was used at 5 pmol/50-µl reaction. The reactions were performed by using a TaqMan Gold reverse transcription-PCR kit (PE Applied Biosystems) and included a 30-min reverse transcription step at 48°C, followed by 10 min at 95°C and by 40 cycles of amplification with universal TaqMan standardized conditions (denaturation for 15 s at 95°C followed by annealing-extension for 1 min at 60°C). Standard RNA was transcribed by using a T7 Megascript kit (Ambion) and was purified by DNase treatment, phenol-chloroform extraction, Sephadex G-50 filtration, and ethanol precipitation. RNA was quantified by measuring the absorbance at 260 nm and was stored at -80°C. All reactions were run in duplicate by using an ABI Prism 7700 or 7900 sequence detection system (PE Applied Biosystems). The PE Applied Biosystems specific primer set was used to quantify the endogenous reference human glyceraldehyde-3-phosphate dehydrogenase mRNA. Whenever necessary, RNA extracted from cells transfected with RNA from replication-defective Rep-GAA mutant constructs was used as a calibrator. Results from two independent experiments were analyzed by using the comparative threshold cycle method.
In vitro translation. In vitro-transcribed RNA (1 µg), prepared as described above, was translated with a rabbit reticulocyte lysate system (Promega) by incubation for 1 h at 30°C in a 30-µl final volume under the conditions suggested by the manufacturer. 35S-Met (Promix; Amersham Pharmacia Biotech) was incorporated as a radioactive tracer. Aliquots of the in vitro translation reaction were analyzed by sodium dodecyl sulfate- 10 or 12% polyacrylamide gel electrophoresis, followed by treatment of the gels with Amplify (Amersham Pharmacia Biotech) and X-ray film exposure. The gels were also scanned with a Storm 820 Phosphorimager (Molecular Dynamics), and densitometric analysis of the radioactive bands was obtained with the program Image Quant.
Nucleotide sequence accession number. The nucleotide sequence of the GBV-B neo-RepB construct is available in the DDBJ/EMBL/GenBank nucleotide sequence database under accession number AJ428955.
| RESULTS |
|---|
|
|
|---|
The portions of the plasmids spanning the inserted core coding sequences are schematized in Fig. 1 both for the series of four replicons bearing the selector gene (encoding neomycin phosphotransferase; neo) and for the series bearing the nonselector reporter gene (encoding ß-lactamase; bla). The A version of each replicon series lacks any core coding sequence, whereas the B, C, and D versions include 21, 39, and 63 nt, respectively, after the AUG start codon. The rationale of the choice of these specific fragments is based on literature data that are referred to in the Discussion. The rationale for the use of both the neo and the bla replicons lies mainly in the possibility of using the first ones to select for replication and the second ones to examine translation efficiency in cells with a convenient colorimetric assay and in the absence of selection.
|
|
In order to achieve detectable levels of replication even shortly after transfection, enhanced cB76.1/Huh7 cells were used as the host and TaqMan was used for analysis, not only because it allows quantitative measurements but also because it is sensitive enough to specifically detect a low number of molecules per cell, such as that of plus-strand GBV-B replicon RNA (10). Unfortunately, in the GBV-B replicon system not even this method is suitable for obtaining reliable results with the much less represented minus-strand RNA, which is the replication intermediate form found in the flaviviruses life cycle. Figure 3 shows the results of TaqMan analysis at 3 days after transfection, in which the intracellular replicon RNA levels reached by the bla-Rep constructs and by a nonreplicating control mutant were measured and compared to the levels reached by each construct in the presence of the known antiviral agent alpha interferon (IFN-
). The results indicated that transient replication of the bla-Rep RNAs only occurred in the absence of IFN-
and was more efficient for constructs including core coding sequences. These results reproducibly confirmed the trend observed with the G418 selection of resistant colonies, i.e., an improvement from RepA to RepD constructs (Fig. 2), although with quantitative differences in the relative efficiencies of the four variants. The latter was especially evident when bla-RepA was compared to the other constructs; e.g., with transient replication, RepD RNA was only threefold more abundant than RepA RNA. The sensitivity to the known antiviral agent IFN-
(Fig. 3) was coherent with the interpretation that the increase in RNA levels was due to replication enhancement rather than to an increase in the stability of the RNA itself.
|
The presence of core coding sequences in GBV-B subgenomic replicons increases the expression of downstream reporter genes in cultured cells and in vitro. We next examined, with both in vivo and in vitro experimental approaches, whether adding core coding sequences between the GBV-B 5'-UTR and downstream genes also affects GBV-B IRES-mediated translation independently from replication. For in vivo experiments, we exploited the ß-lactamase reporter system to examine the expression of the reporter gene in cells transfected with the four bla-Rep constructs described in Fig. 1 by a colorimetric assay (10, 30, 43). To analyze the specific contribution made by the core gene to the efficiency of translation of the downstream bla gene in the absolute absence of replication, we generated a corresponding mutant unable to replicate for each bla-Rep construct. This was done by mutating the GDD motif in the active site of the NS5B polymerase gene into the inactive GAA sequence (10). The cB76.1/Huh7 cell line was transfected with RNA transcribed in vitro from the four bla-Rep-GAA mutant constructs, and the ß-lactamase assay was performed at 4 h after transfection to detect transient expression of the reporter. The results indicated that the ratio between the number of blue cells expressing ß-lactamase and the number of background green cells progressively increased from bla-RepA to bla-RepD (Fig. 4). Moreover, transfection with the construct lacking core coding sequences (bla-RepA) generated only pale blue cells barely distinguishable from green nontransfected cells. All bla-Rep-GAA constructs were confirmed as unable to replicate by TaqMan measurements of RNAs at different times after transfection in cB76.1/Huh7cells (data not shown). The use of replication-defective mutants was chosen to rule out any possibility of replication-dependent artifacts. However, we observed results similar to those obtained with GAA mutants even with replication-competent constructs when we performed the assay at 4 h after transfection (data not shown).
|
|
| DISCUSSION |
|---|
|
|
|---|
For the HCV IRES, several conflicting reports were published a few years ago on the lengths of core coding sequences necessary to achieve efficient translation (27, 35, 37, 42). In a more recent publication (38), these incongruencies were discussed, taking into consideration that previous data had been obtained with different reporters, and a hypothesis that reconciled the different sets of data was advanced. The explanation offered is that in HCV IRES-dependent translation, specific coding sequences are not required, but stable RNA structures immediately downstream of the IRES must be absent. Rijnbrand and colleagues also suggested that in the HCV genome, an A-rich sequence present downstream of the 5'-UTR corresponds to nt 15 to 31 of the coding region (38). This sequence affects the efficiency of translation of the wild-type HCV polyprotein, which is higher than that of some currently used reporters showing strong secondary structures which interfere with binding to ribosomes. Comparison of the HCV genome sequence to that of GBV-B led the authors to hypothesize that an A-rich sequence spanning nt 43 to 59 of the coding region (40 to 56 nt after AUG) plays a similar role in GBV-B. This hypothesis was experimentally tested by inserting a stable hairpin structure at the 5' end of the CAT gene and comparing the efficiencies of translation of RNAs transcribed from constructs with increasingly longer GBV-B core coding sequences with and without that hairpin (38). That experiment demonstrated that the addition of sequences including the putative A-rich box upstream of the CAT gene improved its translation efficiency.
In a previous study aimed at the development of a selectable GBV-B subgenomic dicistronic replicon (10), two versions of the GBV-B replicon, neo-RepA and neo-RepB, were constructed. These contained in the first cistron no GBV-B coding sequence and a stretch of nucleotides of the core gene immediately upstream of the neomycin phosphotransferase gene, respectively. Antibiotic-resistant colonies formed more efficiently when cells were transfected with RNA transcribed from the neo-RepB construct, so that construct was used for subsequent experiments. In order to optimize GBV-B-based constructs, such as chimeric replicons bearing non-GBV-B viral sequences, expected to have a lower intrinsic replication potential, we decided to further analyze the effects of inserting GBV-B coding sequences between the GBV-B 5'-UTR and exogenous genes.
We first compared the efficiencies of colony formation upon transfection of subgenomic constructs bearing core coding regions of increasing lengths up to 63 nt, located between the 5'-UTR and the selector gene used in the previous study (neo). The choice of inserted fragments was based on published data (see above) indicating a possible involvement in translation efficiency of a GBV-B core gene "box" which was included in the longest segment used (38). The results of these experiments confirmed that the number of colonies supporting the replication of GBV-B replicons increased in proportion to the lengths of the added core sequences. The different efficiencies of the overall process of colony formation might imply a variation in the efficiency of GBV-B RNA replication or of translation of the protein responsible for selection or both. To clarify this issue, we performed cell-based short-term experiments and in vitro experiments aimed at separately analyzing the replication and translation processes.
The effect on translation was analyzed, upon transfection of bla replicon mutants defective in replication, by an assay which detects the number of cells expressing the ß-lactamase reporter enzyme. An increase in ß-lactamase activity was observed in correlation with the length of the GBV-B sequences fused to the bla gene, suggesting that the translation controlled by the GBV-B 5'-UTR is influenced by the presence and the length of GBV-B sequences immediately downstream of the regulatory region. The complete absence of core sequences (construct bla-RepA-GAA producing wild-type ß-lactamase) resulted in a low number of positive cells that also were very poorly stained, suggesting that a suboptimal level of ß-lactamase was produced per cell. The effect of the insertion of core sequences on translation was confirmed by in vitro experiments directly measuring the amount of protein produced in a short incubation time with both neo and bla constructs. The findings were consistent with the interpretation that the results of in vivo experiments detecting ß-lactamase activity did reflect the amount of ß-lactamase. Moreover, preliminary data obtained by Western blotting of total proteins from transfected cells show that the lack of core coding sequences actually correlates with the presence of smaller amounts of IRES-dependent translated products even in cells. Nonetheless, although not probable, the possibility cannot in principle be excluded that an increase in the length of the N-terminal partner of the core-reporter fusion proteins may augment the enzymatic activity or stability of the ß-lactamase and/or neomycin phosphotransferase fusion proteins in cells, rather than increase their synthesis, compared to the wild-type proteins.
Our data are comparable to those obtained by Rijnbrand et al. (38) by in vitro transcription-translation of a core-CAT plasmid containing a hairpin loop stabilizing the RNA structure. These data are also compatible with the hypotheses that bla and, to a lesser extent, neo wild-type reporters have 5'-end RNA structures stronger than the corresponding region of the RNA encoding the CAT protein and that the translation efficiency is increased by the insertion of less stable core coding sequences upstream of the reporter genes. The hypothesis that an A-rich box spanning nt 40 to 56 of the GBV-B core gene is responsible for the increase in translation efficiency is not completely matched by our data, since the construct including core sequences up to nt 39 also was efficiently translated. We observed the maximum difference in translation efficiency in the transition from 0 to 21 nt of the core sequence added after the start codon. The effect of inserting core coding sequences upstream of the reporter genes might also be due to nonspecific, sequence-independent spacing which locates the 5' ends of the neo and bla reporter sequences farther from the AUG start codon. We tried to address this issue by applying a computer-based prediction approach, but the predicted stability did not consistently correlate with the observed efficiency of translation of the compared structures (data not shown). We observed that even minor differences in the lengths of the fragments used in folding predictions significantly affected the outcome of the elaborations. On the other hand, achieving an unequivocal experimental demonstration or disproof of the above-mentioned hypotheses exceeds the aim of this study. Our results indicate that, by whatever mechanism, the insertion of GBV-B core coding sequences downstream of the GBV-B IRES enhances the translation of reporter genes. Nonetheless, the quantitative differences observed between the series of bla-Rep and neo-Rep constructs show that sequences downstream of the core coding sequences also may play a role in the efficiency of GBV-B IRES-mediated translation, further confirming that the functional 3' boundary of that IRES extends beyond the start codon.
Besides measuring the effects of core coding sequences on IRES-dependent translation in the absence of replication, we also measured their effects on replication in the absence of selective pressure driven by the IRES-dependent translation product itself. This was achieved by using two types of constructs, one type bearing the usual selector gene (neo) and being transfected into cells cultured in the absence of G418 and one type bearing just a reporter gene (bla). In both situations, GBV-B RNA amounts increased in relation to core gene sequence lengths, suggesting that these sequences also play a role in the replication process. The effect of inserted core sequences on replication was less dramatic than that on protein translation; this finding was especially evident when we analyzed the differences between bla-RepA and the other constructs within the bla-Rep series. At the present time, we do not have data allowing speculations about the mechanism through which core coding sequences are involved in replication, and no information has been reported so far by other groups dealing with any aspect of GBV-B replication. More experiments are necessary to determine whether these regions interact with viral or host cell proteins or with other cis-acting elements of the viral genome directly or by means of long-range bridging proteins, as suggested for HCV (2, 16, 21, 22, 29).
Overall, the above-described data indicate that in GBV-B dicistronic replicons, both replication and expression of genes controlled by the 5' GBV-B IRES are influenced by the presence and length of sequences coding for the N terminus of the GBV-B polyprotein. The effects on GBV-B IRES-mediated translation and replication do not seem to be necessarily linked by a cause-effect relationship, as shown by the possibility of segregating the two functions. The occurrence of independent phenomena might be suggested further by the stronger effect on translation than on transient replication, which was particularly evident with constructs lacking core sequences (RepA constructs), which were clearly more hampered for translation than for replication with respect to constructs bearing core sequences. It is also interesting that even minor effects in either translation or replication efficiency shortly after transfection (as in the case of neo-Rep constructs) might determine a stronger overall difference when combined in a long-term process, such as the selection of antibiotic-resistant cell clones. However, it must considered that, in the G418-based selection process, even very small amounts of neomycin phosphotransferase are sufficient to generate resistance to G418 in cultured cells, as suggested by the transiently resistant cell phenotype observed for several days even with the transfection of replication-deficient mutants (data not shown). This observation is in keeping with the hypothesis that, to determine a higher number of selected colonies bearing the GBV-B replicon, at least in this selection process, an enhancement of RNA replication efficiency is more valuable than an increase in the base levels of neomycin phosphotransferase. An interesting question that remains open is the involvement of core sequences and of coding sequences in general in IRES-dependent translation and in the replication process of the complete viral genome during natural infection.
In conclusion, by analyzing features related to the IRES-dependent translation and replication of GBV-B replicons, we have gained some insight that will aid in the interpretation of data acquired with different reporter systems and in the design of fully functional GBV-B-based constructs, such as genomic selectable replicons and HCV- GBV-B chimeras. The availability of working constructs of this kind will in turn be an important asset for both basic research and drug discovery programs aimed at identifying improved therapies for hepatitis C.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|